# Accuracy, Feasibility and Acceptance of Continuous Glucose Monitoring in Critically Ill Patients

> **NCT02296372** · NA · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 20 (actual)

## Conditions studied

- Glucose Metabolism Disorders
- Diabetic Blood Glucose Monitoring
- Critical Illness

## Interventions

- **DEVICE:** Continuous glucose monitoring

## Key facts

- **NCT ID:** NCT02296372
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-04
- **Final completion:** 2016-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02296372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02296372, "Accuracy, Feasibility and Acceptance of Continuous Glucose Monitoring in Critically Ill Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02296372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*